Author Correction: Initiation and continuation of pharmacological therapies in patients hospitalized for heart failure in Japan

Sci Rep. 2024 Oct 15;14(1):24193. doi: 10.1038/s41598-024-75133-6.

¹ Medical Affairs & Pharmacovigilance, Bayer Yakuhin Ltd, 2-4-9 Umeda, Kita-Ku, Osaka, Breeze Tower, 530-0001, Japan. [email protected].
² Aetion Inc, 5 Penn Plaza, New York, USA.
³ Medical Affairs & Pharmacovigilance, Bayer Yakuhin Ltd, 2-4-9 Umeda, Kita-Ku, Osaka, Breeze Tower, 530-0001, Japan.
⁴ Market Access & Public Affairs, Bayer Yakuhin, Ltd, 2-4-9 Umeda, Kita-Ku, Osaka, Japan.
⁵ Integrated Evidence Generation & Business Innovation, Bayer AG, 13342, Berlin, Germany.
⁶ Integrated Evidence Generation & Business Innovation, Bayer AG, 42096, Wuppertal, Germany.
⁷ Integrated Evidence Generation & Business Innovation, Bayer Consumer Care AG, Peter Merian Straße 84, 4052, Basel, Switzerland.

No abstract available

Publication types